Brief: Biosergen Q1 EBITDA Loss Widens To SEK 6.8 Mln
31/05/2024 07:49
May 31 (Reuters) - Biosergen AB BIOSGN.ST :
* Q1 EBITDA LOSS SEK 6.8 MILLION VERSUS LOSS SEK 5 MILLION
YEAR
AGO
Source text for Eikon: ID:nWkrc2wzZW
Further company coverage: BIOSGN.ST
(Gdansk Newsroom)
((gdansk.newsroom@thomsonreuters.com; +48 58 7696600;))
Recent news on Biosergen AB
See all newsBrief: Nasdaq Approves Biosergen's Delisting Application
Brief: Biosergen Applies For Delisting Of The Company's Shares From Nasdaq First North Growth Market Conditional Upon Completion Of The Merger With Flerie
Brief: Biosergen Resolves On Set-Off Issue
Brief: Biosergen Rights Issue Oversubscribed
Brief: Biosergen Reports H1 EBITDA Of SEK -10.5 Million